当前位置：
X-MOL 学术
›
Cancer Cell
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
When immunotherapy meets surgery in non-small cell lung cancer
Cancer Cell ( IF 48.8 ) Pub Date : 2022-06-02 , DOI: 10.1016/j.ccell.2022.05.010 Roy S Herbst 1 , Meina Wang 1 , Lieping Chen 2
中文翻译：
当免疫疗法遇上非小细胞肺癌手术
更新日期：2022-06-02
Cancer Cell ( IF 48.8 ) Pub Date : 2022-06-02 , DOI: 10.1016/j.ccell.2022.05.010 Roy S Herbst 1 , Meina Wang 1 , Lieping Chen 2
Affiliation
The results of the most recent Checkmate-816 trial in The New England Journal of Medicine using combination neoadjuvant immunotherapy with platinum-based chemotherapy in resectable non-small cell lung cancer demonstrate the effectiveness of neoadjuvant immunotherapy and provide further support that biology and personalized therapy represent the foundation of lung cancer treatment.
中文翻译：
当免疫疗法遇上非小细胞肺癌手术
《新英格兰医学杂志》最近的 Checkmate-816 试验结果表明，新辅助免疫疗法与铂类化学疗法联合用于可切除的非小细胞肺癌，证明了新辅助免疫疗法的有效性，并为生物学和个体化疗法所代表的提供进一步支持肺癌治疗的基础。
京公网安备 11010802027423号